We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MBAV:NASDAQM3-Brigade Acquisition V Corp. Analysis

Data as of 2026-05-19 - not real-time

$10.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $10.805, just above a key support level of $10.72 and below a resistance of $10.89, with the 20‑day SMA (10.805) sitting above the 50‑day (10.785) and 200‑day (10.655) averages, indicating a short‑term bullish alignment. RSI sits near 50, suggesting neutral momentum, while the MACD histogram is slightly negative and the signal line is bearish, hinting at potential short‑term weakness. Volume is trending upward despite today’s low absolute volume, and the beta of ~0.06 combined with a 30‑day volatility of 3.85% points to very low market‑wide price sensitivity. Fundamentally, the company reports zero revenue, a negative book value per share of –$0.54, and an astronomically high trailing P/E of 83 versus an industry average of 16, signaling severe overvaluation. The DCF‑derived fair value of $0.014 is a fraction of the current price, and the max drawdown of –22% underscores the downside risk already realized. The “Extreme Greed” reading on the Fear & Greed Index reflects market optimism that may be disconnected from the underlying financial reality. Overall, the technicals show modest bullish bias, but the fundamentals are profoundly weak, making the stock a high‑risk speculative play.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bullish SMA crossover
  • Bearish MACD signal may limit upside
  • Low beta and volatility reduce market‑wide risk

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential value creation from a future merger or acquisition
  • Increasing volume suggests growing investor interest
  • Current price still above support, offering limited downside

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • No operating business and negative book value
  • Extreme overvaluation relative to DCF fair value
  • High sector and regulatory risk for shell companies

Key Metrics & Analysis

Financial Health

P/E Ratio83.1
ROA-1.34%
P/B Ratio-20.0
Op. Cash Flow$-1465482
Free Cash Flow$142.3K
Industry P/E16.7

Technical Analysis

TrendBullish
RSI50.3
Support$10.72
Resistance$10.89
MA 20$10.81
MA 50$10.78
MA 200$10.66
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25

Valuation

Fair Value$0.01
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.06
Volatility3.85%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.